

Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
-
Thx for taking my money BCRX ,Bye all for second time. Not looking back again. A sincere GLTA.
-
This is getting really scary at this point
-
This thing is headed to 4.50 so obvious
-
Nice volume
-
If it ever gets over $5 again. I want to exit . Time to really get out of this mess! The people in here worried it might drop to two, that is extremely alarming to me.
-
The Emperor Wears No Clothes
-
My own opinion is “The Emperor Wears No Clothes”. This story reminds me of this stock.
-
Another same old same old. Nothing to see here as usual
-
Same old same old. Maybe next month. It must be political.
-
Canceled my latest order. I am back to being negative. Nothing adds up with this stock.
-
I set a limit at 4.95
-
@Biotech is Boomin, can you dumb it down for me , what you just posted, is it bad news, as in holding might not be a good idea? Yes, I am admitting I do not understand the terms you use. Ty for any anticipated reply.
-
8 monthes? Is that the time frame? Please tell me it will be sooner?
-
Thank you Ken for your kindness. Have a great night
-
Could kick myself for getting back in this, nothing will change. False hope is all this is.
-
5.05 seems to be its favorite number today.
-
Please let there be a possible buyout. Why won’t this thing blank or get off the pot already?
-
And here it comes, fishing time, so predictable
-
All biotech stocks are going up but here we are with this one. I wish I had something positive to say.
-
No news on BCRX , I will not add but will play ones with news today.
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2022-05-05 | 2022-03 | -0.39 | -0.4 | -0.01 | -2.56% |
2022-02-23 | 2021-12 | -0.31 | -0.4 | -0.09 | -29.03% |
2021-11-03 | 2021-09 | -0.3 | -0.33 | -0.03 | -10.00% |
2021-08-05 | 2021-06 | -0.22 | -0.24 | -0.02 | -9.09% |
2021-05-06 | 2021-03 | -0.26 | -0.36 | -0.1 | -38.46% |
2021-02-25 | 2020-12 | -0.25 | -0.34 | -0.09 | -36.00% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2022-04-18 | Barclays | Downgrade | Overweight | Equal-Weight |
2022-04-12 | RBC Capital | Upgrade | Sector Perform | |
2022-04-11 | B of A Securities | Downgrade | Buy | Neutral |
2022-04-11 | Oppenheimer | Upgrade | Outperform | |
2021-12-10 | Oppenheimer | Upgrade | Outperform | |
2021-11-04 | RBC Capital | Upgrade | Sector Perform |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2022-04-17 | ABERCROMBIE GEORGE B | Director | 0.00 | Sale |
2022-02-27 | ASELAGE STEPHEN J | Director | 33.16K | Stock Award(Grant) |
2022-03-06 | BABU YARLAGADDA S | Officer | 230.06K | Sale |
2022-02-27 | HEGGIE THERESA | Director | 16.23K | Stock Award(Grant) |
2022-02-27 | INGRAM ROBERT ALEXANDER | Director | 80.06K | Stock Award(Grant) |
2022-02-28 | JONES MICHAEL L. | Officer | 11.20K | Sale |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2022-03-30 | Blackrock Inc. | 14.10M | 229.30M | 7.60% |
2022-03-30 | Vanguard Group, Inc. (The) | 13.21M | 214.75M | 7.12% |
2022-03-30 | Baker Brothers Advisors, LLC | 12.71M | 206.68M | 6.85% |
2022-03-30 | FMR, LLC | 8.41M | 136.82M | 4.53% |
2022-03-30 | State Street Corporation | 7.46M | 121.34M | 4.02% |
2022-03-30 | Pictet Asset Management SA | 5.11M | 83.04M | 2.75% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2022-01-30 | SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 5.30M | 81.83M | 2.85% |
2021-12-30 | Vanguard Total Stock Market Index Fund | 5.11M | 70.78M | 2.75% |
2022-01-30 | iShares Russell 2000 ETF | 4.13M | 63.78M | 2.22% |
2022-02-27 | Fidelity Select Portfolios - Biotechnology | 2.85M | 47.28M | 1.53% |
2021-12-30 | Vanguard Extended Market Index Fund | 2.41M | 33.40M | 1.30% |
2021-12-30 | Artisan International Small-Mid Fund | 1.89M | 26.13M | 1.02% |
Dividend | Date |
---|---|
0 | 2014-06-11 |
0 | 2014-06-05 |
0 | 2014-05-20 |
0 | 2014-05-16 |
0 | 2014-04-02 |